4968 — Arakawa Chemical Industries Balance Sheet
0.000.00%
- ¥23bn
- ¥52bn
- ¥80bn
- 38
- 89
- 66
- 75
Annual balance sheet for Arakawa Chemical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 8,464 | 10,374 | 11,140 | 11,578 | 9,431 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 24,736 | 27,551 | 25,316 | 28,071 | 28,016 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 53,713 | 62,477 | 62,799 | 64,159 | 62,264 |
| Net Property, Plant And Equipment | 38,103 | 40,277 | 40,442 | 39,952 | 39,039 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 105,757 | 117,739 | 119,035 | 125,418 | 122,297 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 33,773 | 36,474 | 42,113 | 43,406 | 37,608 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 48,528 | 58,555 | 64,952 | 69,283 | 63,823 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 57,229 | 59,184 | 54,083 | 56,135 | 58,474 |
| Total Liabilities & Shareholders' Equity | 105,757 | 117,739 | 119,035 | 125,418 | 122,297 |
| Total Common Shares Outstanding |